ShockWave Medical, Inc. (NASDAQ:SWAV) headquartered in Santa Clara, will host a conference call for the investment community to discuss the 3Q20 earnings result on 9th November 2020 at 4:30 PM Eastern Time.
Those interested in listening to the conference call live via the Internet can visit www.shockwavemedical.com
Earnings Expectation
ShockWave Medical, Inc. is expected to report third quarter earnings results, after market close, on Monday 9th November 2020. Analysts polled by Thomson Reuters anticipate third quarter loss of $ 0.55 per share from revenue of $ 14.69 million. Looking ahead, the full year loss are expected at $ 2.21 per share on the revenues of $ 60.29 million.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 74.00 million ~ $ 77.00 million
Click Here For More Historical Outlooks Of ShockWave Medical, Inc.
ShockWave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters or treating below-the-knee peripheral artery disease. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors.
